Online citations, reference lists, and bibliographies.
← Back to Search

Absence Of Germline Mutations In BAP1 In Sporadic Cases Of Malignant Mesothelioma.

Sophie Sneddon, J. S. Leon, I. Dick, G. Cadby, N. Olsen, F. Brims, R. Allcock, E. Moses, P. Melton, N. de Klerk, A. Musk, B. Robinson, J. Creaney
Published 2015 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Malignant mesothelioma (MM) is a uniformly fatal tumour caused predominantly by exposure to asbestos. It is not known why some exposed individuals get mesothelioma and others do not. There is some epidemiological evidence of host susceptibility. BAP1 gene somatic mutations and allelic loss are common in mesothelioma and recently a BAP1 cancer syndrome was described in which affected individuals and families had an increased risk of cancer of multiple types, including MM. To determine if BAP1 mutations could underlie any of the sporadic mesothelioma cases in our cohort of patients, we performed targeted deep sequencing of the BAP1 exome on the IonTorrent Proton sequencer in 115 unrelated MM cases. No exonic germline BAP1 mutations of known functional significance were observed, further supporting the notion that sporadic germline BAP1 mutations are not relevant to the genetic susceptibility of MM.
This paper references
10.1002/ijc.27758
Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia
N. de Klerk (2013)
10.1158/0008-5472.CAN-05-4668
A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent.
C. Robinson (2006)
10.1016/j.ccr.2008.01.030
A conditional mouse model for malignant mesothelioma.
J. Jongsma (2008)
10.1186/1479-5876-10-179
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
M. Carbone (2012)
10.1093/nar/gkq603
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
K. Wang (2010)
10.1038/nprot.2009.86
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
Prateek Kumar (2009)
10.1093/bib/bbs017
Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
H. Thorvaldsdóttir (2013)
10.1073/PNAS.68.4.820
Mutation and cancer: statistical study of retinoblastoma.
A. Knudson (1971)
10.1038/nature02168
The International HapMap Project
T. Tanaka (2003)
10.1038/nmeth0410-248
A method and server for predicting damaging missense mutations
I. Adzhubei (2010)
10.1093/annonc/mdt135
Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation.
C. Ribeiro (2013)
10.1002/gcc.22218
Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high‐risk area
M. Betti (2015)
10.1016/j.canep.2014.02.014
Familial malignant mesothelioma: a population-based study in central Italy (1980-2012).
V. Ascoli (2014)
10.1016/j.lungcan.2014.10.017
Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases.
Andreas Rusch (2015)
10.1038/ng.910
Germline mutations in BAP1 predispose to melanocytic tumors
T. Wiesner (2011)
10.1016/j.lungcan.2013.04.018
A genome-wide association study for malignant mesothelioma risk.
G. Cadby (2013)
10.1038/ng.912
Germline BAP1 mutations predispose to malignant mesothelioma
J. Testa (2011)
10.1158/0008-5472.CAN-14-1328
Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.
Jinfei Xu (2014)
10.1016/j.ajhg.2013.04.012
Germline BAP1 mutations predispose to renal cell carcinomas.
Tatiana Popova (2013)
10.1101/gr.107524.110
The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.
A. McKenna (2010)
10.1016/j.lungcan.2013.11.002
Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the assessment of pleural abnormalities in cancer patients: a systematic review and a meta-analysis.
G. Treglia (2014)



This paper is referenced by
10.3390/ijms21124327
Inherited Genetic Mutations and Polymorphisms in Malignant Mesothelioma: A Comprehensive Review
V. Panou (2020)
10.1016/j.trecan.2016.07.004
Malignant Mesothelioma: Time to Translate?
A. Napolitano (2016)
10.1016/j.lungcan.2017.03.005
Targeting BAP1: a new paradigm for mesothelioma.
L. Schunselaar (2017)
10.1016/j.cancergen.2016.07.002
Mesothelioma families without inheritance of a BAP1 predisposing mutation.
V. Ascoli (2016)
10.1007/s13665-016-0132-1
BAP1 mutations in mesothelioma: advances and controversies
Sophie Sneddon (2016)
10.1080/10937404.2016.1195323
Mesothelioma from asbestos exposures: Epidemiologic patterns and impact in the United States
R. Lemen (2016)
10.1007/978-3-030-16884-1_4
Genetics and Epigenetics of Mesothelioma
A. Aspesi (2019)
10.1016/j.canlet.2016.05.011
CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
M. Betti (2016)
10.21037/jtd.2017.10.41
The genetic susceptibility in the development of malignant pleural mesothelioma.
O. Melaiu (2018)
10.5858/arpa.2017-0365-RA
Malignant Mesothelioma and Its Non-Asbestos Causes.
R. Attanoos (2018)
10.1016/j.lungcan.2018.03.009
Malignant cells from pleural fluids in malignant mesothelioma patients reveal novel mutations.
Sophie Sneddon (2018)
10.4225/23/594a1139df0c6
Molecular characterisation of murine and human malignant mesothelioma and the identification of neoantigens as potential targets for therapy using next generation sequencing
Sophie Sneddon (2017)
10.1016/j.freeradbiomed.2018.10.401
Iron addiction with ferroptosis‐resistance in asbestos‐induced mesothelial carcinogenesis: Toward the era of mesothelioma prevention
S. Toyokuni (2019)
10.1515/pp-2016-0007
Comparative genetics of diffuse malignant mesothelioma tumors of the peritoneumand pleura, with focus on BAP1 expression
M. Brevet (2016)
10.1016/J.MRREV.2019.03.001
Genetic predisposition for malignant mesothelioma: A concise review.
M. Betti (2019)
10.1158/1535-7163.MCT-16-0229
Genomic Landscape of Malignant Mesotheliomas
S. Kato (2016)
10.1002/gcc.22670
Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes
M. Betti (2018)
10.1007/978-3-030-30766-0_19
Malignant Mesothelioma: Mechanism of Carcinogenesis
A. Kane (2014)
10.1200/JCO.2016.34.15_SUPPL.8555
Genomic Landscape of Malignant Mesotheliomas.
S. Kato (2016)
10.1007/978-3-319-53560-9_3
Epidemiology of Mesothelioma
S. Moolgavkar (2017)
1 CDKN 2 A and BAP 1 germline mutations predispose to melanoma and mesothelioma 1
M. Betti ()
10.3390/cancers11081114
Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines
Cindy Chau (2019)
What's new in mesothelioma.
V. Ascoli (2018)
III Italian Consensus Conference on Malignant Mesothelioma of the Pleura. Epidemiology, Public Health and Occupational Medicine related issues.
C. Magnani (2015)
Semantic Scholar Logo Some data provided by SemanticScholar